Placebo News and Research

RSS

Women who took four weeks of prebiotic supplements consumed less sugar, study finds

A new study from the University of Surrey has found that young women who took four weeks of prebiotic supplements made healthier food choices and consumed less sugar.

21 Dec 2021

SGLT2 inhibitor empagliflozin can be used to treat insulin resistance in the brain, finds study

Overweight or obesity, an unfavorable distribution of fat in the body and the development of type 2 diabetes are often associated with a reduced effect of the hormone insulin in many organs, including the brain (insulin resistance).

21 Dec 2021

New oral pill for COVID-19 home treatment

As cases and hospitalizations continue to rise in many countries, new treatments are being sought to arrest the progression of the disease, preventing severe illness and death or disability. One such is the small molecule molnupiravir, the focus of a new research paper.

20 Dec 2021

Anti-SARS-CoV-2 antibody infusion shown to demonstrate robust immune response following COVID-19 vaccination

A new study expands the understanding of the impact of receiving a prophylactic monoclonal antibody infusion, as well as other variables, on the endogenous immune response to complete COVID-19 immunization.

20 Dec 2021

Study examines the effects of methylphenidate on mental fatigue in multiple sclerosis patients

A team of researchers at Kessler Foundation studied the effects of methylphenidate on mental fatigue in individuals with multiple sclerosis (MS). This is the first study to examine the psychostimulant's effects on 'state' vs 'trait' mental fatigue in MS.

18 Dec 2021

Efficacy of NVX-CoV2373 in the US and Mexican adult population

A new study has described the results of PREVENT-19, a phase 3 trial of NVX-CoV2373 that included all adults in the United States and Mexico.

17 Dec 2021

Specific diets have less effect on IBS symptoms than expected

Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms.

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

A new study assesses the safety and efficacy of SARS-CoV-2 convalescent plasma containing high titers of anti-SARS-CoV-2 antibodies as PEP.

16 Dec 2021

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Scientists have recently reported the efficacy of carrageenan against both the SARS-CoV-2 original strain as well as the Alpha, Beta, Gamma, and Delta VOCs.

13 Dec 2021

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care investigated whether nivolumab has an added benefit over watchful waiting in the adjuvant treatment of adults with carcinoma of the esophagus or the gastroesophageal junction and pathological residual disease after prior neoadjuvant chemoradiotherapy (CRT).

10 Dec 2021

NRG Oncology CC004 trial: Bupropion does not improve sexual desire for female cancer survivors

Despite preliminary supporting evidence that the dopaminergic agent bupropion might improve sexual desire for female cancer survivors, the NRG Oncology CC004 clinical trial determined that bupropion did not improve outcomes when compared to a placebo.

10 Dec 2021

Online single-session interventions help curb teen depression, study shows

A study of more than 2,400 adolescents ages 13 to 16 shows two online, single-session interventions designed to help curb teen depression works, a tool very much needed given a rise in teen depression and loss of some in-person mental health services during the Covid-19 pandemic.

9 Dec 2021

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.

9 Dec 2021

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

9 Dec 2021

Placebo News and Research

Women who took four weeks of prebiotic supplements consumed less sugar, study finds

SGLT2 inhibitor empagliflozin can be used to treat insulin resistance in the brain, finds study

New oral pill for COVID-19 home treatment

Anti-SARS-CoV-2 antibody infusion shown to demonstrate robust immune response following COVID-19 vaccination

Study examines the effects of methylphenidate on mental fatigue in multiple sclerosis patients

Efficacy of NVX-CoV2373 in the US and Mexican adult population

Specific diets have less effect on IBS symptoms than expected

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

NRG Oncology CC004 trial: Bupropion does not improve sexual desire for female cancer survivors

Online single-session interventions help curb teen depression, study shows

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Electronic nicotine delivery systems may help some people stop smoking cigarettes

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Diabetes medication could revolutionize treatment for heart failure

Caffeine increases alertness and detection accuracy for moving targets

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News